Home » Topics » BioWorld Science

BioWorld Science
RSS

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Aug. 13, 2021

Nimbus and Schrödinger extend drug discovery collaboration

Aug. 13, 2021

Cogent initiates phase II study of CGT-9486 in systemic mastocytosis

Aug. 13, 2021

Sen-Jam and Duke-NUS Medical School partner to develop novel COVID-19 therapy

Aug. 13, 2021

Mustang Bio and Mayo Clinic collaborate on development of novel CAR T technology

Aug. 13, 2021

FDA clears IND application for first-in-human trial of IO-108

Aug. 13, 2021

VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform

Aug. 13, 2021

SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals

Aug. 13, 2021

Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives

Aug. 13, 2021

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Aug. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...